US37611X2099
US37611X2099
Ginkgo Bioworks Holdings, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 875.42M EUR | 631.38M EUR | 377.98M EUR | 483.7M EUR |
Enterprise Value | 865.59M EUR | 950.96M EUR | 644.82M EUR | 756.39M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -4.48x | -- | -- | -- |
Price to Sales | 6.61x | 5.64x | 2.89x | 4.34x |
Price to Book | 1.97x | 1.5x | 0.85x | 0.95x |
EV/Revenue | 6.54x | 8.5x | 4.93x | 6.79x |
EV/EBITDA | -3.31x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -8.27% | -27.69% | -44.5% | -24.72% |